1.89 USD
▼-0.05-2.58%
盘后 1.94 +2.65%
2026-09-15
市值
$497.72M
市盈率
—
EPS
-1.05
股息率
—
52 周区间
1.18 – 2.58
成交量
978.73K
Beta
2.09
目标价
8.73
52W 低 1.1852W 高 2.58
价格走势
公司简介
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in the United Kingdom and internationally. The company offers AUCATZYL, a gene therapy product consisting of autologous T cells that are transduced with a lentiviral vector to express a novel anti-CD19 chimeric antigen receptor. It also develops obe-cel, which is in phase 1 to treat systemic lupus erythematosus, progressive multiple sclerosis, B-NHL and CLL, and CNS lymphoma; obe-cel, which is in ph...